CVR: 37281603
Forward Pharma FA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity amounted to DKK 39,283.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationScreen owners and management against the Danish FSA's official PEP lists
As of October 27, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Forward Pharma FA ApS.
As of October 27, 2023, Thomas Hagen Weisbjerg has stepped down as liquidator of Forward Pharma FA ApS.
On October 27, 2023, Forward Pharma FA ApS exited liquidation.
Forward Pharma FA ApS was dissolved on October 27, 2023.
Forward Pharma FA ApS has published its annual report for 2022. Gross profit came to DKK -32,125, and the net result was DKK -35,837.
As of June 8, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Forward Pharma FA ApS.
As of June 8, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Forward Pharma FA ApS.
As of March 9, 2023, Claus Bo Søndergaard Svendsen has left the board of directors of Forward Pharma FA ApS.
As of March 9, 2023, Jakob Mosegaard Larsen has left the board of directors of Forward Pharma FA ApS.
As of March 9, 2023, Thomas Hagen Weisbjerg is registered as liquidator of Forward Pharma FA ApS.
As of March 9, 2023, Claus Bo Søndergaard Svendsen has stepped down as director of Forward Pharma FA ApS.
As of March 9, 2023, Florian Schønharting has stepped down as chairman of Forward Pharma FA ApS.
On March 9, 2023, Forward Pharma FA ApS entered liquidation.
Forward Pharma FA ApS has published its annual report for 2021. Gross profit came to DKK -8,250, and the net result was DKK -11,447.
Forward Pharma FA ApS has published its annual report for 2020. Gross profit came to DKK -19,273, and the net result was DKK -23,032.
Forward Pharma FA ApS has published its annual report for 2019. Gross profit came to DKK -30,944, and the net result was DKK -34,096.
Forward Pharma FA ApS has published its annual report for 2018. Gross profit came to DKK -25,125, and the net result was DKK -27,673.
Forward Pharma FA ApS has published its annual report for 2017. Gross profit came to DKK -568,692, and the net result was DKK -447,221.
Forward Pharma FA ApS has published its annual report for 2016. Gross profit came to DKK -2,245,551, and the net result was DKK -1,713,436.
As of May 31, 2017, Claus Bo Søndergaard Svendsen has joined the board of directors of Forward Pharma FA ApS.
As of May 31, 2017, Claus Bo Søndergaard Svendsen is registered as director of Forward Pharma FA ApS.
As of May 31, 2017, Peder Møller Andersen has stepped down as adm. dir. of Forward Pharma FA ApS.
As of December 3, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of Forward Pharma FA ApS.
As of December 3, 2015, Jakob Mosegaard Larsen has joined the board of directors of Forward Pharma FA ApS.
As of December 3, 2015, Peder Møller Andersen is registered as adm. dir. of Forward Pharma FA ApS.
As of December 3, 2015, Florian Schønharting is registered as chairman of Forward Pharma FA ApS.
Forward Pharma FA ApS was founded on December 3, 2015.
companydata.dk